1nym
From Proteopedia
| Line 1: | Line 1: | ||
| - | [[Image:1nym.gif|left|200px]] | + | [[Image:1nym.gif|left|200px]] |
| - | + | ||
| - | '''Crystal Structure of the complex between M182T mutant of TEM-1 and a boronic acid inhibitor (CXB)''' | + | {{Structure |
| + | |PDB= 1nym |SIZE=350|CAPTION= <scene name='initialview01'>1nym</scene>, resolution 1.20Å | ||
| + | |SITE= | ||
| + | |LIGAND= <scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene> and <scene name='pdbligand=CXB:[(2-AMINO-ALPHA-METHOXYIMINO-4-THIAZOLYLACETYL)AMINO]METHYLBORONIC ACID'>CXB</scene> | ||
| + | |ACTIVITY= [http://en.wikipedia.org/wiki/Beta-lactamase Beta-lactamase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.5.2.6 3.5.2.6] | ||
| + | |GENE= bla ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=562 Escherichia coli]) | ||
| + | }} | ||
| + | |||
| + | '''Crystal Structure of the complex between M182T mutant of TEM-1 and a boronic acid inhibitor (CXB)''' | ||
| + | |||
==Overview== | ==Overview== | ||
| Line 7: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
| - | 1NYM is a [ | + | 1NYM is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1NYM OCA]. |
==Reference== | ==Reference== | ||
| - | Recognition and resistance in TEM beta-lactamase., Wang X, Minasov G, Blazquez J, Caselli E, Prati F, Shoichet BK, Biochemistry. 2003 Jul 22;42(28):8434-44. PMID:[http:// | + | Recognition and resistance in TEM beta-lactamase., Wang X, Minasov G, Blazquez J, Caselli E, Prati F, Shoichet BK, Biochemistry. 2003 Jul 22;42(28):8434-44. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/12859188 12859188] |
[[Category: Beta-lactamase]] | [[Category: Beta-lactamase]] | ||
[[Category: Escherichia coli]] | [[Category: Escherichia coli]] | ||
| Line 28: | Line 37: | ||
[[Category: crystal structure]] | [[Category: crystal structure]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 13:03:24 2008'' |
Revision as of 11:03, 20 March 2008
| |||||||
| , resolution 1.20Å | |||||||
|---|---|---|---|---|---|---|---|
| Ligands: | , and | ||||||
| Gene: | bla (Escherichia coli) | ||||||
| Activity: | Beta-lactamase, with EC number 3.5.2.6 | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
Crystal Structure of the complex between M182T mutant of TEM-1 and a boronic acid inhibitor (CXB)
Overview
Developing antimicrobials that are less likely to engender resistance has become an important design criterion as more and more drugs fall victim to resistance mutations. One hypothesis is that the more closely an inhibitor resembles a substrate, the more difficult it will be to develop resistant mutations that can at once disfavor the inhibitor and still recognize the substrate. To investigate this hypothesis, 10 transition-state analogues, of greater or lesser similarity to substrates, were tested for inhibition of TEM-1 beta-lactamase, the most widespread resistance enzyme to penicillin antibiotics. The inhibitors were also tested against four characteristic mutant enzymes: TEM-30, TEM-32, TEM-52, and TEM-64. The inhibitor most similar to the substrate, compound 10, was the most potent inhibitor of the WT enzyme, with a K(i) value of 64 nM. Conversely, compound 10 was the most susceptible to the TEM-30 (R244S) mutant, for which inhibition dropped by over 100-fold. The other inhibitors were relatively impervious to the TEM-30 mutant enzyme. To understand recognition and resistance to these transition-state analogues, the structures of four of these inhibitors in complex with TEM-1 were determined by X-ray crystallography. These structures suggest a structural basis for distinguishing inhibitors that mimic the acylation transition state and those that mimic the deacylation transition state; they also suggest how TEM-30 reduces the affinity of compound 10. In cell culture, this inhibitor reversed the resistance of bacteria to ampicillin, reducing minimum inhibitory concentrations of this penicillin by between 4- and 64-fold, depending on the strain of bacteria. Notwithstanding this activity, the resistance of TEM-30, which is already extant in the clinic, suggests that there can be resistance liabilities with substrate-based design.
About this Structure
1NYM is a Single protein structure of sequence from Escherichia coli. Full crystallographic information is available from OCA.
Reference
Recognition and resistance in TEM beta-lactamase., Wang X, Minasov G, Blazquez J, Caselli E, Prati F, Shoichet BK, Biochemistry. 2003 Jul 22;42(28):8434-44. PMID:12859188
Page seeded by OCA on Thu Mar 20 13:03:24 2008
